Intranasal Etripamil For Conversion of Paroxysmal Supraventricular Tachycardia

Bruce Stambler from Piedmont Heart Institute, Atlanta, Georgia, USA discusses PSVT Node-1 Trial: Intranasal Etripamil For Conversion of Paroxysmal Supraventricular Tachycardia (PSVT) Node-1 Trial.

Filmed by Radcliffe Cardiology on-site at HRS 2017.